Discontinuation report APO-RABEPRAZOLE

Last updated on 2018-10-05 History
Report ID 60717
Drug Identification Number 02345587
Brand name APO-RABEPRAZOLE
Common or Proper name RABEPRAZOLE
Company Name APOTEX INC
Active Ingredient(s) RABEPRAZOLE SODIUM
Strength(s) 20MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL
Packaging size 100 BTL
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for discontinuation Business reasons
Anticipated discontinuation date 2018-09-30
Actual discontinuation date 2018-09-28
Remaining supply date 2018-09-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-10-05 French Compare
v3 2018-10-05 English Compare
v2 2018-09-08 French Compare
v1 2018-09-08 English Compare